Sight Diagnostics is a private medical device company that uses advanced computer-vision and machine-learning technology in the field of blood diagnostics.

Sight Diagnostics, developing a point-of-care CBC platform which will provide a five-point differential blood count for use in

Sight Diagnostic’s is applying its technology to the complete blood count (CBC) point of care (i.e., doctors’ office and emergency medical centers) market. The OLO^® device is a marketed, US FDA and CE approved, device that uses blood taken directly from either a finger prick or a venous sample.

Sight Diagnostic’s also developed the Parasight platform, which is a highly accurate, easy-to-use device for diagnosing malaria.